Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease

Christian P. Selinger*, Andrew Robinson, Rupert W. Leong

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

43 Citations (Scopus)


Introduction: Inflammatory bowel diseases (IBDs) require maintenance medication to sustain remission and as a prophylaxis against the development of colorectal dysplasia. Non-adherence can compromise the effectiveness of treatment plans. Areas covered: Depending on study cohort and country, 7 72% of IBD patients do not adhere to maintenance medication plans. Non-adherence is associated with an increased number of flares and increased healthcare utilization costs. Several factors, such as experiencing side effects and demographic, socioeconomic, disease-specific and psychological variables have been associated with non-adherence in IBD. Data on demographic, socioeconomic and disease-specific variables are inconsistent, while data on psychological distress, patients' beliefs about medication and discordant doctorpatient relationships are more consistently associated with non-adherence. There has been a change towards investigation of modifiable factors for non-adherence in the recent literature. Expert opinion: Currently, there is no simple and effective intervention to improve adherence to IBD maintenance medication. Anxiety, beliefs about medicines and the doctorpatient relationship are promising targets for interventions, but require further study.

Original languageEnglish
Pages (from-to)863-870
Number of pages8
JournalExpert Opinion on Drug Safety
Issue number6
Publication statusPublished - Nov 2011
Externally publishedYes


  • Adherence
  • Adverse events
  • Inflammatory bowel disease
  • Maintenance medication


Dive into the research topics of 'Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this